Old Web
English
Sign In
Acemap
>
Paper
>
Lamivudine-resistant HIVM184V is Durably Suppressed with Dolutegravir plus Lamivudine Dual Therapy in Humanized Mice
Lamivudine-resistant HIVM184V is Durably Suppressed with Dolutegravir plus Lamivudine Dual Therapy in Humanized Mice
2020
Sandra Medina-Moreno
Juan C. Zapata
Fatah Kashanchi
Nhut Le
Said Hassounah
Thibault Mesplède
Maureen Oliveira
Charles C. Davis
Alonso Heredia
Keywords:
Dolutegravir
Lamivudine
Virology
Medicine
dual therapy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
0
Citations
NaN
KQI
[]